Skip to content

Implementation of the Core trial: placement of naso-enteral feeding tubes by ward nurses.

Implementation of the Core trial: placement of naso-enteral feeding tubes by ward nurses.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23363
Enrollment
53
Registered
2016-01-04
Start date
2016-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients on a gastrointestinal surgical wards with an indication for enteral nutrition via a nasoenteral feeding tube, as indicated by the treating physician and/or consulting dietitian.

Interventions

Naso-enteral feeding tube placement by surgical ward nurse

Sponsors

Academic Medical Center, Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Adult patients admitted to gastrointestinal surgical wards with an indication for a nasoenteral feeding tube

Exclusion criteria

Exclusion criteria: - contraindication for enteral feeding or EM guided placement, patients requiring tube placement during weekends or with unavailability from the trained nurses

Design outcomes

Primary

MeasureTime frame
interval between physician order, tube placement

Secondary

MeasureTime frame
- interval between physician order and start feeding - need for reinsertion of the feeding tube (e.g. after failed initial placement or due to tube related complications) - success rate of primary tube placement - patient-reported outcomes (patient CRF after placement) - tube (placement) related complications, such as clogging, kinking, fall out - duration of the tube placement procedure - duration of tube feeding - duration of primary tube stay - need for feeding related interventions (including EM guided repositioning without reinsertion of the tube) - use of parenteral nutrition - length of hospital stay; in-hospital mortality;

Contacts

Public ContactTimothy Mungroop
t.h.mungroop@amc.nl0031 6 22 14 64 88

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)